Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Asan Medical Center
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically confirmed adenocarcinoma of the prostate
Clinical or radiologic evidence of metastatic disease
Documented disease progression during hormone therapy (ADT plus antiandrogen) and no response to ADT withdrawal
Docetaxel-refractory disease defined as disease progression documented either during treatment of within 60 days after the cessation of treatment with docetaxel
Prior exposure to estramustine or mitoxantrone is allowed
KPS ≥ 60
No prior radioisotope therapy
No prior radiotherapy 25% or more of the bone marrow
